CONTACT US  |  ACCOUNT LOGIN   THE VAP CHOLESTEROL TEST | ATHEROTECH DIAGNOSTIC TESTS | OUR HEALTHY HEART | THE LIPID LIBRARY | ABOUT ATHEROTECH   Inflammation Markers The Lipid Library Clinical Studies Return to Clinical Studies C Reactive Protein-hs Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein Number needed to treat with rosuvastatin to prevent first cardiovascular events and death among men and women with low low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein: justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin (JUPITER). CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: laboratory tests available to assess inflammation--performance and standardization: a background paper. Lp-PLA2 Consensus Panel Recommendation for Incorporating Lipoprotein-Associated Phospholipase A2 Testing into Cardiovascular Disease Risk Assessment Guidelines The role of lipoprotein-associated phospholipase A2 in atherosclerosis may depend on its lipoprotein carrier in plasma. Lipoprotein-associated phospholipase A(2) and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies. Return to Clinical Studies "Cardiovascular disease is the leading cause of death and disease in U.S. Detailed lipid information from the VAP test can be very helpful to busy clinicians in their efforts to identify, treat and track the dyslipidemias which cause cardiovascular disease." - Eliot A. Brinton, M.D., Director of the Metabolism Section of Cardiovascular Genetics, Director of the LDL Apheresis Center, and Associate Professor at the University of Utah School of Medicine THE VAP CHOLESTEROL TEST  |  ATHEROTECH DIAGNOSTIC TESTS  |  OUR HEALTHY HEART  |  THE LIPID LIBRARY  |  ABOUT ATHEROTECH © Copyright 2012. Atherotech. All rights reserved.